Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing 100191, China; National Health Commission Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University, Beijing 100191, China.
Department of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Peking University Center for Human Disease Genomics, Key Laboratory of Medical Immunology, Ministry of Health, Beijing 100191, China.
Matrix Biol. 2023 May;119:1-18. doi: 10.1016/j.matbio.2023.03.007. Epub 2023 Mar 22.
Decreased vascular compliance of the large arteries as indicated by increased pulse wave velocity is shown to be associated with atherosclerosis and the related cardiovascular events. The positive correlation between arterial stiffening and disease progression derives a hypothesis that softening the arterial wall may protect against atherosclerosis, despite that the mechanisms controlling the cellular pathological changes in disease progression remain unknown. Here, we established a mechanical-property-based screening to look for compounds alleviating the arterial wall stiffness through their actions on the interaction between vascular smooth muscle cells (VSMCs) and the wall extracellular matrix (ECM). We found that echinatin, a chalcone preferentially accumulated in roots and rhizomes of licorice (Glycyrrhiza inflata), reduced the stiffness of ECM surrounding cultured VSMCs. We examined the potential beneficial effects of echinatin on mitigating arterial stiffening and atherosclerosis, and explored the mechanistic basis by which the compound exert the effects. Administration of echinatin in mice fed on an adenine diet and in hyperlipidemia mice subjected to 5/6 nephrectomy mitigated arterial stiffening and atherosclerosis. Mechanistic insights were gained from the RNA-sequencing results showing that echinatin upregulated the expression of glutamate cysteine ligases (GCLs), both the catalytic (GCLC) and modulatory (GCLM) subunits. Further study indicated that upregulation of GCLC/GCLM in VSMCs by echinatin maintains the homeostasis of glutathione (GSH) metabolism; adequate availability of GSH is critical for counteracting arterial stiffening. As a consequence of regulating the GSH synthesis, echinatin inhibits ferroptosis and matrix remodeling that being considered two contributors of arterial stiffening and atherosclerosis. These data demonstrate a pivotal role of GSH dysregulation in damaging the proper VSMC-ECM interaction and uncover a beneficial activity of echinatin in preventing vascular diseases.
大动脉血管顺应性降低,表现为脉搏波速度增加,与动脉粥样硬化及相关心血管事件相关。动脉僵硬度与疾病进展之间存在正相关关系,这一假说认为,动脉壁软化可能有助于预防动脉粥样硬化,尽管控制疾病进展中细胞病理变化的机制尚不清楚。在这里,我们建立了一种基于力学特性的筛选方法,寻找通过作用于血管平滑肌细胞(VSMCs)与壁细胞外基质(ECM)之间的相互作用来缓解动脉壁僵硬的化合物。我们发现,在甘草(Glycyrrhiza inflata)的根和根茎中优先积累的查尔酮化合物——獐牙菜苦苷(echinatin),可降低培养的 VSMCs 周围 ECM 的僵硬程度。我们检验了獐牙菜苦苷在减轻动脉僵硬度和动脉粥样硬化方面的潜在有益作用,并探讨了该化合物发挥作用的机制基础。在给予腺嘌呤饮食喂养的小鼠和 5/6 肾切除高脂血症小鼠獐牙菜苦苷治疗后,可减轻动脉僵硬度和动脉粥样硬化。从 RNA 测序结果中获得的机制见解表明,獐牙菜苦苷上调了谷氨酸半胱氨酸连接酶(GCLs)的表达,包括催化亚基(GCLC)和调节亚基(GCLM)。进一步的研究表明,獐牙菜苦苷在 VSMCs 中上调 GCLC/GCLM 的表达,维持谷胱甘肽(GSH)代谢的平衡;GSH 的充足供应对于对抗动脉僵硬度至关重要。由于调节 GSH 的合成,獐牙菜苦苷抑制铁死亡和基质重塑,这被认为是动脉僵硬度和动脉粥样硬化的两个贡献因素。这些数据表明,GSH 失调在破坏适当的 VSMC-ECM 相互作用中起着关键作用,并揭示了獐牙菜苦苷在预防血管疾病方面的有益活性。